[Classification of liver incidents occurring during antitubercular treatments which include rifampicin].
D000410:Alanine Transaminase / Q000097:blood; D000995:Antitubercular Agents / Q000009:adverse effects*; D001219:Aspartate Aminotransferases / Q000097:blood; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D006506:Hepatitis A / Q000209:etiology; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D007565:Jaundice / Q000097:blood; D008107:Liver Diseases / Q000145:classification; D011537:Pruritus / Q000139:chemically induced; D012293:Rifampin / Q000009:adverse effects* / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy
D000995:Antitubercular Agents; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D012293:Rifampin
Essai de classification des accidents hépatiques survenant au cours des traitements antituberculeux comportant de la Rifampicine